Christian Schöneich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christian Schöneich has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Susan W. Hovorka
Department of Pharmaceutical Chemistry, University of Kansas, Lawrence 66047, USA
3 shared publicationsMichael J. Hageman
Research and Development, Pharmacia Corporation, Kalamazoo, Michigan 49007
2 shared publicationsTodd D. Williams
Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, and Mass Spectrometry Laboratory, The University of Kansas, Lawrence, Kansas 66045
2 shared publicationsAndreas Hühmer
Proteomic Technologies, ThermoFinnigan Corporation, San Jose
1 shared publicationBrian L. Miller
Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, USA
1 shared publication- Charles B. Glaser
307 Greene St., Mill Valley, CA. 94941, United States
1 shared publication
Latest Publications
- 1 January 2005
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1703 (2) , 111-119
Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease
- 1 January 2005
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1703 (2) , 111-119
Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease
- 30 November 2004
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1703 (2) , 91-92
Preface
- 30 November 2004
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1703 (2) , 91-92
Preface
- 1 May 2004
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 93 (5) , 1122-1130
Selective Site-Specific Fenton Oxidation of Methionine in Model Peptides: Evidence for a Metal-Bound Oxidant
- 1 May 2004
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 93 (5) , 1122-1130
Selective Site-Specific Fenton Oxidation of Methionine in Model Peptides: Evidence for a Metal-Bound Oxidant
- 1 March 2004
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1012 (1) , 164-170
Selective Cu2+/Ascorbate‐Dependent Oxidation of Alzheimer's Disease β‐Amyloid Peptides
Abstract: This review summarizes tandem mass spectrometric investigations on the selectivity of metal‐catalyzed oxidation of β‐amyloid peptide (βAP) and related sequences. A remarkable feature of the Cu2+/ascorbate‐dependent oxidation of these peptides is the switch from predominantly His oxidation in the neurotoxic peptide βAP1‐40 to predominantly Tyr oxidation in the nonneurotoxic reverse sequence βAP40‐1. Within βAP1‐40, His13 and His14 of the high‐affinity Cu2+‐binding site are most sensitive to oxidation. Eventually, the oxidation of one or both of these His residues could result in a less redox‐active βAP‐Cu2+ complex, lowering the incidence of βAP‐Cu2+‐dependent Fenton‐type reactions for the benefit of surrounding biological tissue.
- 1 March 2004
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1012 (1) , 164-170
Selective Cu2+/Ascorbate‐Dependent Oxidation of Alzheimer's Disease β‐Amyloid Peptides
Abstract: This review summarizes tandem mass spectrometric investigations on the selectivity of metal‐catalyzed oxidation of β‐amyloid peptide (βAP) and related sequences. A remarkable feature of the Cu2+/ascorbate‐dependent oxidation of these peptides is the switch from predominantly His oxidation in the neurotoxic peptide βAP1‐40 to predominantly Tyr oxidation in the nonneurotoxic reverse sequence βAP40‐1. Within βAP1‐40, His13 and His14 of the high‐affinity Cu2+‐binding site are most sensitive to oxidation. Eventually, the oxidation of one or both of these His residues could result in a less redox‐active βAP‐Cu2+ complex, lowering the incidence of βAP‐Cu2+‐dependent Fenton‐type reactions for the benefit of surrounding biological tissue.
- 18 October 2003
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 125 (45) , 13700-13713
Free Radical Reactions of Methionine in Peptides: Mechanisms Relevant to β-Amyloid Oxidation and Alzheimer's Disease
The pathogenesis of Alzheimer's disease is strongly associated with the formation and deposition of β-amyloid peptide (βAP) in the brain. This peptide contains a methionine (Met) residue in the C-terminal domain, which is important for its neurotoxicity and its propensity to reduce transition metals and to form reactive oxygen species. Theoretical studies have proposed the formation of βAP Met radical cations as intermediates, but no experimental evidence with regard to formation and reactivity of these species in βAP is available, largely due to the insolubility of the peptide. To define the potential reactions of Met radical cations in βAP, we have performed time-resolved UV spectroscopic and conductivity studies with small model peptides, which show for the first time that (i) Met radical cations in peptides can be stabilized through bond formation with either the oxygen or the nitrogen atoms of adjacent peptide bonds; (ii) the formation of sulfur−oxygen bonds is kinetically preferred, but on longer time scales, sulfur−oxygen bonds convert into sulfur−nitrogen bonds in a pH-dependent manner; and (iii) ultimately, sulfur−nitrogen bonded radicals may transform intramolecularly into carbon-centered radicals located on the αC moiety of the peptide backbone.
- 18 October 2003
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 125 (45) , 13700-13713
Free Radical Reactions of Methionine in Peptides: Mechanisms Relevant to β-Amyloid Oxidation and Alzheimer's Disease
The pathogenesis of Alzheimer's disease is strongly associated with the formation and deposition of β-amyloid peptide (βAP) in the brain. This peptide contains a methionine (Met) residue in the C-terminal domain, which is important for its neurotoxicity and its propensity to reduce transition metals and to form reactive oxygen species. Theoretical studies have proposed the formation of βAP Met radical cations as intermediates, but no experimental evidence with regard to formation and reactivity of these species in βAP is available, largely due to the insolubility of the peptide. To define the potential reactions of Met radical cations in βAP, we have performed time-resolved UV spectroscopic and conductivity studies with small model peptides, which show for the first time that (i) Met radical cations in peptides can be stabilized through bond formation with either the oxygen or the nitrogen atoms of adjacent peptide bonds; (ii) the formation of sulfur−oxygen bonds is kinetically preferred, but on longer time scales, sulfur−oxygen bonds convert into sulfur−nitrogen bonds in a pH-dependent manner; and (iii) ultimately, sulfur−nitrogen bonded radicals may transform intramolecularly into carbon-centered radicals located on the αC moiety of the peptide backbone.
- 1 August 2003
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 92 (8) , 1698-1709
Solid-State Photodegradation of Bovine Somatotropin (Bovine Growth Hormone): Evidence for Tryptophan-Mediated Photooxidation of Disulfide Bonds
- 1 August 2003
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 92 (8) , 1698-1709
Solid-State Photodegradation of Bovine Somatotropin (Bovine Growth Hormone): Evidence for Tryptophan-Mediated Photooxidation of Disulfide Bonds
- 1 July 2003
- Vol. 49 (5) , 753-61
CU(II)-catalyzed oxidation of Alzheimer's disease beta-amyloid peptide and related sequences: remarkably different selectivities of neurotoxic betaAP1-40 and non-toxic betaAP40-1.
We investigated the CuII-catalyzed oxidation of beta-amyloid peptides betaAP10-20 and betaAP40-1 by tandem mass spectrometry and compared oxidation yields and selectivities to those for betaAP1-16, betaAP1-28 and betaAP1-40, which were obtained earlier (26). While betaAP1-16, betaAP1-28 and betaAP1-40 showed an almost exclusive oxidation of His residues to 2-oxo-histidine, the selectivity pattern is changed for betaAP10-20,which shows oxidation of His but also hydroxylation of Tyr and Phe. In contrast to betaAP1-40, the reverse sequence betaAP40-1 shows a strong selectivity for the hydroxylation of Tyr31 while only negligible His oxidation is observed at early time points. These selectivity patterns show the importance of the geometry of the metal-binding site for peptide/protein oxidation. The significantly different characteristic of betaAP1-40 and betaAP40-1 with regard to metal catalyzed processes may be related to the differences in the neurotoxic properties of these sequences.
- 1 July 2003
- Vol. 49 (5) , 753-61
CU(II)-catalyzed oxidation of Alzheimer's disease beta-amyloid peptide and related sequences: remarkably different selectivities of neurotoxic betaAP1-40 and non-toxic betaAP40-1.
We investigated the CuII-catalyzed oxidation of beta-amyloid peptides betaAP10-20 and betaAP40-1 by tandem mass spectrometry and compared oxidation yields and selectivities to those for betaAP1-16, betaAP1-28 and betaAP1-40, which were obtained earlier (26). While betaAP1-16, betaAP1-28 and betaAP1-40 showed an almost exclusive oxidation of His residues to 2-oxo-histidine, the selectivity pattern is changed for betaAP10-20,which shows oxidation of His but also hydroxylation of Tyr and Phe. In contrast to betaAP1-40, the reverse sequence betaAP40-1 shows a strong selectivity for the hydroxylation of Tyr31 while only negligible His oxidation is observed at early time points. These selectivity patterns show the importance of the geometry of the metal-binding site for peptide/protein oxidation. The significantly different characteristic of betaAP1-40 and betaAP40-1 with regard to metal catalyzed processes may be related to the differences in the neurotoxic properties of these sequences.
- 14 March 2003
- Published by Elsevier in Experimental Gerontology
- Vol. 38 (5) , 473-481
Proteomics in gerontological research
- 14 March 2003
- Published by Elsevier in Experimental Gerontology
- Vol. 38 (5) , 473-481
Proteomics in gerontological research
- 5 April 2002
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 15 (5) , 717-722
Cu(II)-Catalyzed Oxidation of β-Amyloid Peptide Targets His13and His14over His6: Detection of 2-Oxo-histidine by HPLC-MS/MS
The interaction of β-amyloid peptide (βAP) with Cu(II) leads to the formation of reactive oxygen species, neurotoxicity, and the chemical modification of the peptide. To study product formation and the potential selectivity of oxidation, we have exposed specific βAP congeners, βAP1−16, βAP1−28, and βAP1−40, to ascorbate/Cu(II)-induced metal-catalyzed oxidation and electrospray ionization-time-of-flight (ESI-TOF) MS/MS analysis. Incubation of 30 μM βAP with 15−150 μM Cu(II) and (physiologically relevant) 720 μM ascorbate in 20 mM phosphate buffer, pH 7.4, leads to significant oxidation of the peptides within remarkably short reaction times of as low as 6 min. Initial oxidation targets are His13 and His14, which are converted to 2-oxo-His, whereas the other two metal-binding residues, His6 and Tyr10, remain intact. Longer oxidation times then also target His6. Even in βAP1−40 the oxidation of His13 and His14 precedes the oxidation of Met35. Especially, the insensitivity of Tyr10 is noteworthy and may be explained by electron withdrawal from the Tyr side chain through complexation of Cu(II). The insensitivity of His6 to initial oxidation may be rationalized by a proposed bridging of two Cu(II)-βAP congeners, lowering the electron density on His6, comparable to similar results on a Cu(II)- and Zn(II)-bridging His61 residue of bovine Cu,Zn superoxide dismutase.
- 5 April 2002
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 15 (5) , 717-722
Cu(II)-Catalyzed Oxidation of β-Amyloid Peptide Targets His13and His14over His6: Detection of 2-Oxo-histidine by HPLC-MS/MS
The interaction of β-amyloid peptide (βAP) with Cu(II) leads to the formation of reactive oxygen species, neurotoxicity, and the chemical modification of the peptide. To study product formation and the potential selectivity of oxidation, we have exposed specific βAP congeners, βAP1−16, βAP1−28, and βAP1−40, to ascorbate/Cu(II)-induced metal-catalyzed oxidation and electrospray ionization-time-of-flight (ESI-TOF) MS/MS analysis. Incubation of 30 μM βAP with 15−150 μM Cu(II) and (physiologically relevant) 720 μM ascorbate in 20 mM phosphate buffer, pH 7.4, leads to significant oxidation of the peptides within remarkably short reaction times of as low as 6 min. Initial oxidation targets are His13 and His14, which are converted to 2-oxo-His, whereas the other two metal-binding residues, His6 and Tyr10, remain intact. Longer oxidation times then also target His6. Even in βAP1−40 the oxidation of His13 and His14 precedes the oxidation of Met35. Especially, the insensitivity of Tyr10 is noteworthy and may be explained by electron withdrawal from the Tyr side chain through complexation of Cu(II). The insensitivity of His6 to initial oxidation may be rationalized by a proposed bridging of two Cu(II)-βAP congeners, lowering the electron density on His6, comparable to similar results on a Cu(II)- and Zn(II)-bridging His61 residue of bovine Cu,Zn superoxide dismutase.
- 1 April 2002
- Published by Springer Nature in Pharmaceutical Research
- Vol. 19 (4) , 530-537
High Sensitivity of Zn2+ Insulin to Metal-Catalyzed Oxidation: Detection of 2-Oxo-Histidine by Tandem Mass Spectrometry
Purpose. To establish the sensitivity of Zn2+ insulin (Zn2+-INS) to metal-catalyzed oxidation (MCO) and to use tandem mass spectrometry/mass spectroscopy (MS/MS) for the identification and quantification of 2-oxo-histidine at 5HisB and 10HisB upon the MCO of INS. Methods. Zn2+-INS was exposed to Cu2+/ascorbate-induced MCO. Products were analyzed by reverse-phase high-performance liquid chromatography, electrospray ionization mass spectrometry (ESI-MS) and MS/MS, sodium dodecylsulfate polyacrylamide gel electrophotesis (SDS-PAGE), and CD spectroscopy. Results. A maximal loss of 40% INS was achieved when 20 μM INS/8.8μM Zn2+ were exposed to 8 μM Cu2+ and 50 μM ascorbate. MCO was completely inhibited by ethylenediaminetetraacetic acid or native catalase but not with a 1000-fold molar excess of Zn2+ over Cu2+. MCO did not alter the aggregation state of INS. High-performance liquid chromatography-fractionated products contained portions of oxidized and native INS monomers. Oxidation selectively targeted the B chain of INS, where MS/MS sequencing revealed 2-oxo-His formation at both His residues at a relative ratio of 10HisB-ox/5HisB-ox = 2.8 ± 1.3 (SD). Conclusions. At a Zn2+/INS molar ratio comparable to that in regular INS preparations, Zn2+-INS was susceptible to MCO. Both His residues of INS were converted partially to 2-oxo-His, with 10HisB possessing ca. three times greater susceptibility to MCO than 5HisB.
- 1 April 2002
- Published by Springer Nature in Pharmaceutical Research
- Vol. 19 (4) , 530-537
High Sensitivity of Zn2+ Insulin to Metal-Catalyzed Oxidation: Detection of 2-Oxo-Histidine by Tandem Mass Spectrometry
Purpose. To establish the sensitivity of Zn2+ insulin (Zn2+-INS) to metal-catalyzed oxidation (MCO) and to use tandem mass spectrometry/mass spectroscopy (MS/MS) for the identification and quantification of 2-oxo-histidine at 5HisB and 10HisB upon the MCO of INS. Methods. Zn2+-INS was exposed to Cu2+/ascorbate-induced MCO. Products were analyzed by reverse-phase high-performance liquid chromatography, electrospray ionization mass spectrometry (ESI-MS) and MS/MS, sodium dodecylsulfate polyacrylamide gel electrophotesis (SDS-PAGE), and CD spectroscopy. Results. A maximal loss of 40% INS was achieved when 20 μM INS/8.8μM Zn2+ were exposed to 8 μM Cu2+ and 50 μM ascorbate. MCO was completely inhibited by ethylenediaminetetraacetic acid or native catalase but not with a 1000-fold molar excess of Zn2+ over Cu2+. MCO did not alter the aggregation state of INS. High-performance liquid chromatography-fractionated products contained portions of oxidized and native INS monomers. Oxidation selectively targeted the B chain of INS, where MS/MS sequencing revealed 2-oxo-His formation at both His residues at a relative ratio of 10HisB-ox/5HisB-ox = 2.8 ± 1.3 (SD). Conclusions. At a Zn2+/INS molar ratio comparable to that in regular INS preparations, Zn2+-INS was susceptible to MCO. Both His residues of INS were converted partially to 2-oxo-His, with 10HisB possessing ca. three times greater susceptibility to MCO than 5HisB.